Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03286842
Title To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca

Her2-receptor negative breast cancer



Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

No variant requirements are available.